World's Best Scientists 2026 revealed!
Giovanni Martinelli

Giovanni Martinelli

Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
132
Citations
72651
World Ranking
2298
National Ranking
49

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Giovanni Martinelli is affiliated with the University of Bologna in Italy. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with specialized work in hematology, molecular biology, oncology, genetics, and public health, environmental and occupational health.

The main topics of their research include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia Research
  • CAR-T Cell Therapy Research
  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research

Martinelli's body of work has been published frequently in several prominent journals. These publication venues include:

  • Blood
  • Frontiers in Oncology
  • Cancers
  • Panminerva Medica
  • Journal of Clinical Oncology

Their recent notable publications feature works such as:

  • "MDM2 inhibition: an important step forward in cancer therapy" (2020), published in Leukemia
  • "A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target" (2020), published in Journal of Hematology & Oncology
  • "Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels" (2020), published in bioRxiv (Cold Spring Harbor Laboratory)
  • "Colour deconvolution: stain unmixing in histological imaging" (2020), published in Bioinformatics
  • "Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia" (2020), published in Journal of Clinical Oncology

Their collaborative network includes frequent coauthors such as:

  • Claudio Cerchione
  • Giorgia Simonetti
  • Giovanni Marconi
  • Cristina Papayannidis
  • Antonio Curti

Martinelli's research contributions cover a broad spectrum of hematologic malignancies and molecular pathways, contributing to understanding leukemia pathophysiology and treatment options. Their work reflects ongoing involvement in cancer therapies, immune response dynamics, and histological analysis methods within the biomedical research community.

Best Publications

  • European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Michele Baccarani;Michael W. Deininger;Gianantonio Rosti;Andreas Hochhaus

  • Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

    Hagop M. Kantarjian;Daniel J. DeAngelo;Matthias Stelljes;Giovanni Martinelli

  • Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition

    Daniela Cardinale;Alessandro Colombo;Maria T. Sandri;Giuseppina Lamantia

  • International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

    Hervé Dombret;John F. Seymour;Aleksandra Butrym;Agnieszka Wierzbowska

  • Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

    Timothy P Hughes;Michael W Deininger;Andreas Hochhaus;Susan Branford

  • Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy

    Daniela Cardinale;Maria T. Sandri;Alessandro Colombo;Nicola Colombo

  • Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML

    Alexander E. Perl;Giovanni Martinelli;Jorge E. Cortes;Andreas Neubauer

  • Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

    Massimo Federico;Monica Bellei;Luigi Marcheselli;Stefano Luminari

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

    Giampaolo Bucaneve;Alessandra Micozzi;Francesco Menichetti;Pietro Martino

  • Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

    Daniela Cardinale;Maria Teresa Sandri;Alessandro Martinoni;Alessio Tricca

  • Contribution of ABL Kinase Domain Mutations to Imatinib Resistance in Different Subsets of Philadelphia-Positive Patients: By the GIMEMA Working Party on Chronic Myeloid Leukemia

    Simona Soverini;Sabrina Colarossi;Alessandra Gnani;Gianantonio Rosti

  • Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule

    Michele Ghielmini;Shu Fang Hsu Schmitz;Sergio B. Cogliatti;Gabriella Pichert

  • Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

    E. Zucca;A. Conconi;T.I. Mughal;A.H. Sarris

  • Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

    Patrizia Mancuso;Alessandra Burlini;Giancarlo Pruneri;Aron Goldhirsch

  • Very young women (<35 years) with operable breast cancer: features of disease at presentation

    M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando

  • Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

    Hagop M. Kantarjian;Francis J. Giles;Kapil N. Bhalla;Javier A. Pinilla-Ibarz

  • Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    Robin Foà;Antonella Vitale;Marco Vignetti;Giovanna Meloni

  • Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    Alexander E. Perl;Jessica K. Altman;Jorge Cortes;Catherine Smith

  • Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    Simona Soverini;Andreas Hochhaus;Franck E. Nicolini;Franz Gruber

Frequent Co-Authors

Michele Baccarani
Michele Baccarani University of Bologna
Michele Cavo
Michele Cavo University of Bologna
Giuseppe Saglio
Giuseppe Saglio University of Turin
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Sante Tura
Sante Tura University of Bologna
Jorge E. Cortes
Jorge E. Cortes Augusta University
Giorgina Specchia
Giorgina Specchia University of Bari Aldo Moro
Massimo Delledonne
Massimo Delledonne University of Verona
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Medicine but seeking flexible or alternative educational opportunities, online degrees offer a wide range of career-focused options. The rise of online health administration programs makes it easier to develop essential leadership skills for healthcare settings, even while balancing other commitments.

If you are an RN looking to advance your clinical role, the rn to np bridge program provides a fast-track pathway to becoming a nurse practitioner. These programs are designed for working nurses who want to deepen their expertise and expand their career options.

For those focusing on preventative care and wellness, online nutrition degrees build foundational knowledge in health, diet, and chronic disease management—opening doors in clinical, community, and business environments.

Aspiring healthcare leaders should also consider programs with recognized credentials like a cahme accredited online mha programs list, which ensures high educational standards and broad career prospects in health administration.

Best Scientists Citing Giovanni Martinelli

Trending Scientists